FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034975008> ?p ?o ?g. }

• W2034975008 endingPage "33" @default.
• W2034975008 startingPage "33" @default.
• W2034975008 abstract "Invasive Aspergillus infections in hospitalized patients with chronic lung disease Mireya Wessolossky,1 Verna L Welch,2 Ajanta Sen,1 Tara M Babu,1 David R Luke21Division of Infectious Diseases, University of Massachusetts Medical School, Worcester, MA, USA; 2Medical Affairs, Pfizer Inc, Collegeville, PA, USABackground: Although invasive pulmonary aspergillosis (IPA) is more prevalent in immunocompromised patients, critical care clinicians need to be aware of the occurrence of IPA in the nontraditional host, such as a patient with chronic lung disease. The purpose of this study was to describe the IPA patient with chronic lung disease and compare the data with that of immunocompromised patients.Methods: The records of 351 patients with Aspergillus were evaluated in this single-center, retrospective study for evidence and outcomes of IPA. The outcomes of 57 patients with chronic lung disease and 56 immunocompromised patients were compared. Patients with chronic lung disease were defined by one of the following descriptive terms: emphysema, asthma, idiopathic lung disease, bronchitis, bronchiectasis, sarcoid, or pulmonary leukostasis.Results: Baseline demographics were similar between the two groups. Patients with chronic lung disease were primarily defined by emphysema (61%) and asthma (18%), and immunocompromised patients primarily had malignancies (27%) and bone marrow transplants (14%). A higher proportion of patients with chronic lung disease had a diagnosis of IPA by bronchoalveolar lavage versus the immunocompromised group (P < 0.03). The major risk factors for IPA were found to be steroid use in the chronic lung disease group and neutropenia and prior surgical procedures in the immunocompromised group. Overall, 53% and 69% of chronic lung disease and immunocompromised patients were cured (P = 0.14); 55% of chronic lung patients and 47% of immunocompromised patients survived one month (P = 0.75).Conclusion: Nontraditional patients with IPA, such as those with chronic lung disease, have outcomes and mortality similar to that in the more traditional immunocompromised population.Keywords: Aspergillus, moulds, intensive care units, chronic lung disease, antifungals" @default.
• W2034975008 created "2016-06-24" @default.
• W2034975008 creator A5007873527 @default.
• W2034975008 creator A5019629197 @default.
• W2034975008 creator A5040664696 @default.
• W2034975008 creator A5040905527 @default.
• W2034975008 creator A5052572039 @default.
• W2034975008 date "2013-05-01" @default.
• W2034975008 modified "2023-10-14" @default.
• W2034975008 title "Invasive Aspergillus infections in hospitalized patients with chronic lung disease" @default.
• W2034975008 cites W122074435 @default.
• W2034975008 cites W1969880613 @default.
• W2034975008 cites W1978003912 @default.
• W2034975008 cites W2000445173 @default.
• W2034975008 cites W2002874690 @default.
• W2034975008 cites W2003164555 @default.
• W2034975008 cites W2012665468 @default.
• W2034975008 cites W2015915634 @default.
• W2034975008 cites W2018755852 @default.
• W2034975008 cites W2031233251 @default.
• W2034975008 cites W2036173051 @default.
• W2034975008 cites W2039267791 @default.
• W2034975008 cites W2039458277 @default.
• W2034975008 cites W2043274291 @default.
• W2034975008 cites W2046655138 @default.
• W2034975008 cites W2047902382 @default.
• W2034975008 cites W2055390591 @default.
• W2034975008 cites W2056431674 @default.
• W2034975008 cites W2058271592 @default.
• W2034975008 cites W2082430018 @default.
• W2034975008 cites W2088447454 @default.
• W2034975008 cites W2094213584 @default.
• W2034975008 cites W2106895832 @default.
• W2034975008 cites W2108396393 @default.
• W2034975008 cites W2109488389 @default.
• W2034975008 cites W2119962983 @default.
• W2034975008 cites W2120466624 @default.
• W2034975008 cites W2121025359 @default.
• W2034975008 cites W2123134253 @default.
• W2034975008 cites W2129940902 @default.
• W2034975008 cites W2136374304 @default.
• W2034975008 cites W2141436450 @default.
• W2034975008 cites W2145577370 @default.
• W2034975008 cites W2146711485 @default.
• W2034975008 cites W2147723584 @default.
• W2034975008 cites W2149855395 @default.
• W2034975008 cites W2158272308 @default.
• W2034975008 cites W2166734004 @default.
• W2034975008 cites W2168264398 @default.
• W2034975008 cites W2333267067 @default.
• W2034975008 cites W2345998326 @default.
• W2034975008 cites W2398574278 @default.
• W2034975008 cites W2441762207 @default.
• W2034975008 cites W2464077565 @default.
• W2034975008 cites W9959341 @default.
• W2034975008 doi "https://doi.org/10.2147/idr.s43069" @default.
• W2034975008 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3674018" @default.
• W2034975008 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23761976" @default.
• W2034975008 hasPublicationYear "2013" @default.
• W2034975008 type Work @default.
• W2034975008 sameAs 2034975008 @default.
• W2034975008 citedByCount "6" @default.
• W2034975008 countsByYear W20349750082015 @default.
• W2034975008 countsByYear W20349750082016 @default.
• W2034975008 countsByYear W20349750082017 @default.
• W2034975008 countsByYear W20349750082019 @default.
• W2034975008 countsByYear W20349750082020 @default.
• W2034975008 countsByYear W20349750082021 @default.
• W2034975008 crossrefType "journal-article" @default.
• W2034975008 hasAuthorship W2034975008A5007873527 @default.
• W2034975008 hasAuthorship W2034975008A5019629197 @default.
• W2034975008 hasAuthorship W2034975008A5040664696 @default.
• W2034975008 hasAuthorship W2034975008A5040905527 @default.
• W2034975008 hasAuthorship W2034975008A5052572039 @default.
• W2034975008 hasBestOaLocation W20349750081 @default.
• W2034975008 hasConcept C126322002 @default.
• W2034975008 hasConcept C203014093 @default.
• W2034975008 hasConcept C2776391196 @default.
• W2034975008 hasConcept C2777714996 @default.
• W2034975008 hasConcept C2777961210 @default.
• W2034975008 hasConcept C2779379686 @default.
• W2034975008 hasConcept C2992694001 @default.
• W2034975008 hasConcept C71924100 @default.
• W2034975008 hasConceptScore W2034975008C126322002 @default.
• W2034975008 hasConceptScore W2034975008C203014093 @default.
• W2034975008 hasConceptScore W2034975008C2776391196 @default.
• W2034975008 hasConceptScore W2034975008C2777714996 @default.
• W2034975008 hasConceptScore W2034975008C2777961210 @default.
• W2034975008 hasConceptScore W2034975008C2779379686 @default.
• W2034975008 hasConceptScore W2034975008C2992694001 @default.
• W2034975008 hasConceptScore W2034975008C71924100 @default.
• W2034975008 hasLocation W20349750081 @default.
• W2034975008 hasLocation W20349750082 @default.
• W2034975008 hasLocation W20349750083 @default.
• W2034975008 hasLocation W20349750084 @default.
• W2034975008 hasOpenAccess W2034975008 @default.
• W2034975008 hasPrimaryLocation W20349750081 @default.
• W2034975008 hasRelatedWork W2369037761 @default.

• next